Brown Advisory’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Brown Advisory’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-28,000	Closed	-$5.32K	–	1248
2023 Q2	$5.32K	Hold	28,000	–	–	﹤0.01%	1178
2023 Q1	$9.52K	Hold	28,000	–	–	﹤0.01%	1202
2022 Q4	$9.05K	Hold	28,000	–	–	﹤0.01%	1198
2022 Q3	$12K	Buy	+28,000	New	+$11.1K	﹤0.01%	1128
2021 Q4	–	Sell	-18,700	Closed	-$39K	–	1294
2021 Q3	$39K	Hold	18,700	–	–	﹤0.01%	1095
2021 Q2	$30K	Hold	18,700	–	–	﹤0.01%	1064
2021 Q1	$42K	Hold	18,700	–	–	﹤0.01%	1073
2020 Q4	$46K	Hold	18,700	–	–	﹤0.01%	1006
2020 Q3	$46K	Hold	18,700	–	–	﹤0.01%	952
2020 Q2	$66K	Hold	18,700	–	–	﹤0.01%	927
2020 Q1	$44K	Sell	18,700 -8,000	-30%	-$22.5K	﹤0.01%	922
2019 Q4	$59K	Hold	26,700	–	–	﹤0.01%	1022
2019 Q3	$49K	Hold	26,700	–	–	﹤0.01%	991
2019 Q2	$39K	Hold	26,700	–	–	﹤0.01%	1016
2019 Q1	$53K	Hold	26,700	–	–	﹤0.01%	1300
2018 Q4	$34K	Buy	+26,700	New	+$48.9K	﹤0.01%	1232
2018 Q3	–	Sell	-26,700	Closed	-$90K	–	1387
2018 Q2	$90K	Hold	26,700	–	–	﹤0.01%	1255
2018 Q1	$113K	Buy	+26,700	New	+$92.5K	﹤0.01%	1136
2017 Q1	–	Sell	-28,000	Closed	-$74K	–	1200
2016 Q4	$74K	Hold	28,000	–	–	﹤0.01%	1112
2016 Q3	$91K	Hold	28,000	–	–	﹤0.01%	1042
2016 Q2	$94K	Hold	28,000	–	–	﹤0.01%	1018
2016 Q1	$69K	Hold	28,000	–	–	﹤0.01%	975
2015 Q4	$92K	Buy	28,000 +10,000	+56%	+$33.5K	﹤0.01%	933
2015 Q3	$62K	Buy	18,000 +8,000	+80%	+$18.6K	﹤0.01%	921
2015 Q2	$13K	Sell	10,000 -8,000	-44%	-$11.2K	﹤0.01%	860
2015 Q1	$15K	Hold	18,000	–	–	﹤0.01%	927
2014 Q4	$7K	Hold	18,000	–	–	﹤0.01%	925
2014 Q3	$78K	Buy	+18,000	New	+$88.2K	﹤0.01%	927

Other funds holding NYMX

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

CAM

Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return

ODIJL

One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Brown Advisory's NYMX Position: Q3 2023 in Review

Brown Advisory sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 28,000 shares — an estimated $5.32K sold.

Brown Advisory first reported a position in NYMX in Q3 2014 and held it in 28 quarters. The position peaked at $113K in Q1 2018. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

Brown Advisory reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
Brown Advisory sold 28,000 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $5.32K.
Brown Advisory first reported a position in Nymox Pharmaceutical Corp in Q3 2014 and held it in 28 quarters.
Brown Advisory's Nymox Pharmaceutical Corp position peaked at $113K in Q1 2018.
5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Brown Advisory's 13F filing for Q3 2023, filed 25 Oct 2023.